documents: FDA-2016-N-0400-0023
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-N-0400-0023 | FDA | FDA-2016-N-0400 | Reference 21 - Eliminating the Blood Outbreaks of Hepatitis B Virus Infection and the Need for Innovative Glucose Monitoring Technologies re General and Plastic Surgery Devices; Reclassification of Blood Lancets | Supporting & Related Material | Background Material | 2016-03-07T05:00:00Z | 2016 | 3 | 2016-03-07T17:03:57Z | 0 | 0 | 0900006481e9ecc9 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref